Please assess the completion status of the following clinical trial:

Trial Title: Nebulised Hypertonic Saline in Children and Young People With Neuromuscular Disease and Cerebral Palsy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Children with Neuromuscular disease or Cerebral Palsy who have been on treatment with nebulised Hypertonic Saline for at least 12 months.~Exclusion Criteria:~* Children also diagnosed with cystic fibrosis.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 18 Years
- Healthy Volunteers: None

Study Arms:
- Before treatment (Type: None): Children and young people with neuromuscular disease during the 12 months before being prescribed treatment with nebulised saline (0.9% - 7%)
- After treatment (Type: None): Children and young people with neuromuscular disease during the 12 months after being prescribed treatment with nebulised saline (0.9% - 7%)

Based on this trial design, predict the completion outcome and termination type (if applicable).